As we come together to recognize World Cancer Day in February 2024, it’s important to acknowledge the significant strides being made in cancer care. (123) BioReference continues to be at the forefront of these efforts, demonstrating a steadfast commitment to advancing oncology testing, tailored precision medicine, collaborative care and support, advancements in cancer research, and […]
Tag Archives: oncology
Blog
The Power of Data Integration: Transforming Oncology Outcomes with Clinical and Genomic Insights
07
Dec
Dec
In the world of healthcare, data has become essential to driving better patient outcomes. From clinical records to genomic insights, the convergence of various data sources is revolutionizing research and development (R&D) in pharmaceutical companies. In this article, we will explore the remarkable potential of real-world data (RWD), particularly in oncology, and how its integration […]
Press Release
BioReference® Signs On as the First Laboratory to Use MSK-ACCESS® Powered with SOPHiA DDM™
07
Nov
Nov
World-class liquid biopsy testing will be made commercially available to BioReference® customers across the country BOSTON, MA, ELMWOOD PARK, NJ, and Rolle, Switzerland, November 7, 2023 – SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software company and a leader in data-driven medicine, today announced that BioReference® Health, LLC, an OPKO Health, Inc. company and full-service laboratory that […]
21
Apr
Apr
In 2022, it’s estimated that 9,910 new cases of testicular cancer will be diagnosed in the United States, according to the American Cancer Society.1 This April, for Testicular Cancer Awareness Month, we’re highlighting some key information to help raise awareness and encourage education – read on for five important things to know about testicular cancer. […]
Press Release
BioReference Laboratories Showcases 2019 Growth through the Addition of Cutting Edge Tests, Greater Access to Services, and Optimized Patient Experience
19
Dec
Dec
ELMWOOD PARK, N.J., December 19, 2019 – BioReference Laboratories, Inc., an OPKO Health Company, along with its genetics and genomics laboratory, GeneDx, Inc., and oncology, urology and women’s health division, GenPath Diagnostics, are pleased to provide a 2019 business update, highlighting new tests that lead to faster diagnoses, payer relationships that provide greater access to […]
